Seeking Alpha

OncoMed Pharmaceuticals EPS of -$0.53

  • OncoMed Pharmaceuticals (NASDAQ:OMED): Q2 EPS of -$0.53 may not be comparable to consensus of -$0.03.
  • Revenue of $6M (+104.8% Y/Y) misses by $15.28M.
  • Press Release
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs